Other Earnings and Cash Flow Stats:
BECTON DICKINSON & CO ( BDX ) Net Income TTM ($MM) is 1726.00
BECTON DICKINSON & CO ( BDX ) Operating Income TTM ($MM) is 2425.00
BECTON DICKINSON & CO ( BDX ) Owners' Earnings Annual ($MM) is 3761.33
BECTON DICKINSON & CO ( BDX ) Current Price to Owners' Earnings ratio is 18.31
BECTON DICKINSON & CO ( BDX ) EBITDA TTM ($MM) is 4693.00
BECTON DICKINSON & CO ( BDX ) EBITDA Margin is 23.49%
Capital Allocation:
BECTON DICKINSON & CO ( BDX ) has paid 4.16 dividends per share and bought back -2.617 million shares in the past 12 months
BECTON DICKINSON & CO ( BDX ) has increased its debt by 3003.0 million USD in the last 12 months
Capital Structure:
BECTON DICKINSON & CO ( BDX ) Interest-bearing Debt ($MM) as of last quarter is 18882
BECTON DICKINSON & CO ( BDX ) Annual Working Capital Investments ($MM) are 2045
BECTON DICKINSON & CO ( BDX ) Book Value ($MM) as of last quarter is 38404
BECTON DICKINSON & CO ( BDX ) Debt/Capital as of last quarter is 72%
Other Balance Sheet Stats:
BECTON DICKINSON & CO ( BDX ) has 1717 million in cash on hand as of last quarter
BECTON DICKINSON & CO ( BDX ) has 8956 million of liabilities due within 12 months, and long term debt 19132 as of last quarter
BECTON DICKINSON & CO ( BDX ) has 291 common shares outstanding as of last quarter
BECTON DICKINSON & CO ( BDX ) has 0 million USD of preferred stock value
Academic Scores:
BECTON DICKINSON & CO ( BDX ) Altman Z-Score is 3.05 as of last quarter
BECTON DICKINSON & CO ( BDX ) Piotroski Score is 6.00 as of last quarter
Corporate Governance:
BECTON DICKINSON & CO ( BDX ) largest shareholder is owning shares at 0.00 ($MM) value
Garrison Michael David(an insider) Sold 2838 shares of BECTON DICKINSON & CO ( BDX ) for the amount of $633810.54 on 2024-12-19
0.28% of BECTON DICKINSON & CO ( BDX ) is held by insiders, and 90.75% is held by institutions
BECTON DICKINSON & CO ( BDX ) went public on 1987-01-01
Other BECTON DICKINSON & CO ( BDX ) financial metrics:
FCF:3222.00
Unlevered Free Cash Flow:1860.00
EPS:5.79
Operating Margin:11.96
Gross Profit Margin:100.00
Div. Payout Ratio%:70.14
Div. Growth YoY%:14.29
Equity Return%:6.50
Beta:0.41
Buffet's Owners Earnings:3761.33
Price to Owner's Earnings:18.31
About BECTON DICKINSON & CO ( BDX ) :
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes; and prefillable drug delivery systems. Its BD Life Sciences segment offers specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The company's BD Interventional segment provides hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention, surgical and laparoscopic instrumentation products; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is based in Franklin Lakes, New Jersey.
DISCLAIMER
This web site and its creators are not certified financial advisors. All opinions/suggestions expressed on this website should not be treated as specific inducement to make a particular investment or follow a particular strategy, but only as an expression of an opinion.The Company doesn't warrant the information provided on the website for its completeness or accuracy, and it should not be relied upon as such. The Company is not under any obligation to update or correct any information provided on this website.The content of this website is published in the United States of America and persons who access it agree to do so in accordance with applicable U.S. law.Past performance is not indicative of future results. The Company doesn't guarantee any specific outcome or profit. You should be aware of the real risk of loss in following any strategy or investment discussed on this website.Strategies or investments discussed may fluctuate in price or value. Investors may get back less than invested. Investments or strategies mentioned on this website may not be suitable for you. This material does not take into account your particular investment objectives,financial situation or needs and is not intended as recommendations appropriate for you. You must make an independent decision regarding investments or strategies mentioned on this website. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.